CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

March 25th, 2011

FDA Approves 2 New Cardiac Resynchronization Therapy-Pacemaker Systems From Medtronic

The FDA has approved two new cardiac resynchronization therapy-pacemaker (CRT-P) systems manufactured by Medtronic, the company announced. Both the Consulta® and Syncra™ CRT-P systems include an ECG reporting system, which works with the company’s network data monitoring system to offer remote follow-up of heart-failure patients. In addition, the Consulta includes Medtronic’s fluid monitoring system and a capture management feature that provides automatic pacing adjustment in response to physiologic changes.

Categories: Electrophysiology, Heart Failure
Tags: ,


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.